173186-91-9

Basic information

• Product Name: 1-BENZYL-3,3-DIMETHYL-PIPERIDIN-4-ONE
• Synonyms: 1-BENZYL-3,3-DIMETHYL-PIPERIDIN-4-ONE;1-Benzyl-3,3-dimethyl-4-piperidone;N-Benzyl-3,3-dimethyl-4-piperidone
• CAS NO: 173186-91-9
• Molecular Formula: C₁₄H₁₉NO
• Molecular Weight: 217.31
• Mol File: 173186-91-9.mol

Chemical Properties

• Boiling Point: 317.995 °C at 760 mmHg
• Flash Point: 136.723 °C
• Appearance: /
• Density: 1.031 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 7.14±0.40(Predicted)
• CAS DataBase Reference: 1-BENZYL-3,3-DIMETHYL-PIPERIDIN-4-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BENZYL-3,3-DIMETHYL-PIPERIDIN-4-ONE(173186-91-9)
• EPA Substance Registry System: 1-BENZYL-3,3-DIMETHYL-PIPERIDIN-4-ONE(173186-91-9)

Safety Data

• Hazardous Substances Data: 173186-91-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Benzyl-3,3-Dimethyl-Piperidin-4-one is used as a chemical intermediate for the synthesis of active pharmaceutical ingredients (APIs). It serves as a key component in the development of numerous medications, contributing to the advancement of pharmaceutical chemistry.
Used in Research and Development:
1-Benzyl-3,3-Dimethyl-Piperidin-4-one is utilized as a research compound in scientific studies, allowing researchers to explore its properties and potential applications in the field of medicine and drug development. This helps in the discovery of new therapeutic agents and the improvement of existing ones.

Upstream product

• 563-80-4 3-methyl-butan-2-one 
• 50-00-0 formaldehyd 
• 100-46-9 benzylamine 
• 34737-89-8 1-Benzyl-3-methyl-4-piperidon 
• 74-88-4 methyl iodide 
• 324769-02-0 (rac)-1-Benzyl-3,3-dimethyl-piperidin-4-ol 
• 3612-20-2 1-phenylmethyl-4-piperidone 
• 7087-68-5 N-ethyl-N,N-diisopropylamine 
• 1589566-77-7 2,2-dimethyl-3-[(2-iodoethyl)(phenylmethyl)amino]-propanoic acid methyl ester 
• 31648-35-8 1-benzyl-3,3-dimethyl-2,4-piperidinedione 

Downstream Products

• 324769-06-4 tert-butyl 3,3-dimethyl-4-oxopiperidine-1-carboxylate 
• 396133-38-3 (±)-4-amino-3,3-dimethylpiperidine 
• 473838-43-6 1-benzyl-4-ethylamino-3,3-dimethylpiperidine 
• 473838-47-0 1-benzyl-4-cyclopropylamino-3,3-dimethyl piperidine 
• 150668-82-9 3,3-Dimethyl-piperidin-4-one 
• 570409-63-1 tert-butyl 3-amino-8,8-dimethyl-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate 
• 570409-62-0 t-butyl 8,8-dimethyl-3-nitro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate 
• 647010-76-2 3-(3-chloro-4-methoxy-benzoylamino)-8,8-dimethyl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester 
• 647010-78-4 3-(3-bromo-4-methoxy-benzoylamino)-8,8-dimethyl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester 
• 647010-74-0 3-(3-fluoro-4-methoxy-benzoylamino)-8,8-dimethyl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester 
• 647010-80-8 3-(4-methoxy-3-trifluoromethyl-benzoylamino)-8,8-dimethyl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester 
• 647010-83-1 3-(4-isopropoxy-3-trifluoromethyl-benzoylamino)-8,8-dimethyl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester 
• 647010-82-0 3-(4-ethoxy-3-trifluoromethyl-benzoylamino)-8,8-dimethyl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester 
• 635732-39-7 C₂₁H₂₈N₂ 

Relevant articles and documents

ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE

Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.

5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

The disclosure relates particularly to certain carboxamide, sulfonamide and amine compounds and pharmaceutical compositions thereof, and to methods of treating and ameliorating disorders and conditions related to the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage and metabolic inefficiency, among others. In certain embodiments, the compounds have the structures (I-1), (2-I) and (3-I) in which the variables are as described herein.

CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.

BENZAMIDE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER

The present invention is directed to benzamide derivatives, pharmaceutical compositions containing them, and their use as FASN inhibitors, in for example, the treatment of cancer, obesity related disorders, liver related disorders and viral infections. Such compounds are represented by formula (I) as follows: wherein R1, R2, R3, R4, R5, m, n, (II) and (III) are defined herein.

A novel and concise synthetic access to chiral 2-substituted-4-piperidone

A novel and concise synthetic access to enantiopure chiral 2-aryl/alkyl substituted 4-piperidone has been demonstrated. This new route features two key steps: the highly diastereoselective conjugate addition of homochiral lithium amides to trans-β-substituted-α,β-unsaturated methyl esters guaranteed the enantiopurity at 2 position (de >19:1) and the intramolecular attacking of carbanions to methyl esters led to the formation of the piperidone ring. A wide range of substrates, including chiral 2-aryl and 2-alkyl-4-piperidones, were successfully synthesized with modest to high yield. Moreover, some non-chiral 3-substituted-4-piperidones were also synthesized with enhanced ring-formation yield, implicating the versatility of this method in construction of various piperidine rings.

CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF

Provided are a condensed pyridine derivative having a serotonin 5-HT2C receptor activation action, a prophylactic or therapeutic agent for a lower urinary tract symptom, obesity and/or organ prolapse and the like containing the condensed pyridine derivative, a screening method for a substance that increases leak point pressure upon a rise in the intravesical pressure or a prophylactic or therapeutic drug for stress urinary incontinence, a prophylactic or therapeutic drug for cystoceles or enteroceles, containing a substance that activates serotonin 5-HT2C receptor, and a method of screening for a therapeutic drug for cystoceles or enteroceles, including increasing an intravesical pressure after bilateral transection of the hypogastric nerve and pudendal nerve of an animal, and measuring a closure response in the urethra, the rectum or the vagina observed at that time. A serotonin 5-HT2C receptor activator containing a compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof.

NOVEL SUBSTITUTED PIPERIDONES AS HSP INDUCERS

The present invention relates to novel compounds of formula (I) or (II), their pharmaceutically acceptable salts and their hydrates, solvates, stereoisomers, conformers, tautomers, polymorphs and prodrugs and also pharmaceutically acceptable compositions containing them Wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification. The compounds of the present invention are HSP inducers and by virtue of this effect, useful for the treatment of various diseases accompanying pathological stress. The present invention also relates to a process for the preparation of the said novel compounds. The invention also relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.

PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disease, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.

PIPERIDINOYL-PYRROLIDINE AND PIPERIDINOYL-PIPERIDINE COMPOUNDS

The present invention relates to a class of compounds of general formula (I) and the salts, hydrates, solvates, polymorphs and prodrugs wherein n, R6, R7 and R10 are as defined herein and especially to MCR4 agonist compounds of formula (I), to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.

Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments

This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.